Consistent with these observations, reduced Tfpi2 expression has been correlated with cancer progression, recurrence and poor prognosis, and it is downregulated in several aggressive tumors, including BC, CRC, PC, HCC, PCC and NSCLC [98,99,100,101,102,103]. This evidence concerns the gene TFPI2 and colorectal carcinoma.